Introduction: When Should You Seek Diagnostic Testing?

If you have a family history of high triglycerides or heart disease that appeared before age 50, it’s worth talking to your doctor about getting tested for familial hypertriglyceridemia. This genetic condition often runs in families, meaning that if your parents had elevated triglyceride levels, you’re more likely to develop them too. Because this disorder follows an autosomal dominant inheritance pattern—a way genetic traits pass from parent to child—each child of an affected parent has about a 50% chance of inheriting the condition.^[1][2]

Most people with familial hypertriglyceridemia don’t notice any symptoms in their daily lives. The condition typically remains hidden until puberty or early adulthood when triglyceride levels begin to climb. However, just because you feel fine doesn’t mean the condition isn’t affecting your health. High triglyceride levels quietly increase your risk of developing atherosclerotic cardiovascular disease—a condition where fatty deposits build up in your arteries—and in severe cases, can lead to a painful and dangerous inflammation of the pancreas called acute pancreatitis.^[1][2]

Getting tested becomes especially important if you have other health conditions that often appear alongside familial hypertriglyceridemia. These include obesity, high blood sugar levels (hyperglycemia), high blood pressure (hypertension), or diabetes. Each of these conditions can push already elevated triglyceride levels even higher, creating a more dangerous situation for your health. Additionally, certain lifestyle factors like drinking alcohol, eating a diet high in refined carbohydrates and sugars, or taking specific medications (such as some birth control pills) can worsen triglyceride levels in people with this genetic predisposition.^[2][11]

Early detection through diagnostic testing is crucial because familial hypertriglyceridemia is treatable, especially when caught before complications develop. If you notice that close family members have required heart treatments at young ages or have been diagnosed with high triglycerides, don’t wait for symptoms to appear. Having these conversations with your parents and siblings about family medical history can provide valuable clues that help your doctor determine whether you need testing.^[2][16]

Classic Diagnostic Methods

Blood Tests for Triglyceride Levels

The primary way doctors diagnose familial hypertriglyceridemia is through a simple blood test that measures the amount of triglycerides in your bloodstream. This test requires you to fast—meaning you shouldn’t eat or drink anything except water—for eight to twelve hours before your blood is drawn. Fasting is important because eating can temporarily raise triglyceride levels, making it difficult to get an accurate picture of your baseline levels. Your doctor will typically ask you to have blood drawn in the morning after an overnight fast.^[2][4]

When your results come back, your doctor will look at specific numbers to determine if you have hypertriglyceridemia. A normal triglyceride level is below 150 milligrams per deciliter (mg/dL), with levels below 100 mg/dL considered ideal. If your results show triglycerides of 150 mg/dL or higher, you meet the definition of hypertriglyceridemia. Blood tests in people with familial hypertriglyceridemia most often reveal mild to moderate elevations, typically ranging from about 200 to 500 mg/dL. However, when combined with other health conditions or lifestyle factors, these levels can climb much higher.^[2][4]

The severity of your condition is classified based on how high your triglycerides measure. Borderline high levels fall between 150 and 199 mg/dL, while high triglycerides range from 200 to 499 mg/dL. Very high or severe hypertriglyceridemia means your levels have reached 500 mg/dL or higher. When triglycerides climb this high, the risk of developing acute pancreatitis increases significantly, making immediate treatment essential.^[4][8]

Additional Blood Markers

Besides measuring triglycerides directly, your doctor will also look at other blood fats to understand your complete lipid profile. People with familial hypertriglyceridemia typically have high levels of very low-density lipoproteins (VLDL)—particles that carry triglycerides through your bloodstream. The liver produces too many of these VLDL particles in people with this genetic condition, leading to the accumulation of triglycerides in the blood.^[1][2]

Your lipid panel will also show your cholesterol levels. In familial hypertriglyceridemia, LDL cholesterol (often called “bad” cholesterol) and HDL cholesterol (the “good” cholesterol) are often low. This combination of high triglycerides with low HDL cholesterol is particularly concerning because it increases cardiovascular disease risk. Your doctor might also order a test to measure apolipoprotein B (apo B), a protein found on certain lipoproteins. Research has shown that people with familial hypertriglyceridemia tend to have lower apo B levels compared to people with other causes of high triglycerides, which can help distinguish this genetic condition from other forms of elevated triglycerides.^[2][6]

A coronary risk profile might also be performed to assess your overall risk of heart disease. This evaluation takes into account not just your lipid levels, but also other factors like blood pressure, blood sugar, and family history to give a complete picture of your cardiovascular health.^[2]

Physical Examination

Your doctor will perform a thorough physical examination looking for visible signs that might suggest severely elevated triglycerides. One key sign is the presence of xanthomas—small, yellowish bumps that appear on the skin, particularly on the elbows, knees, buttocks, or eyelids. These deposits form when triglyceride levels become very high, though many people with mild to moderate familial hypertriglyceridemia never develop them.^[1][4]

Another finding that can appear during an eye examination is lipemia retinalis, a condition where the blood vessels in the back of your eye appear creamy or milky white due to extremely high triglyceride levels. Your doctor might also check for an enlarged liver (hepatomegaly) by feeling your abdomen, as fat accumulation in the liver can occur with severe hypertriglyceridemia.^[1]

Family Medical History Assessment

Taking a detailed family medical history is a crucial part of diagnosing familial hypertriglyceridemia. Your doctor will ask specific questions about whether your parents, siblings, or other close relatives have had high triglycerides, early heart disease (before age 50), heart attacks, or strokes at young ages. This information helps establish whether there’s a genetic pattern in your family. Because familial hypertriglyceridemia follows an autosomal dominant inheritance pattern, finding that a parent or sibling has the condition significantly increases the likelihood that you might have it too.^[1][2]

Your doctor will also explore whether family members have experienced acute pancreatitis, as repeated episodes of pancreatic inflammation in a family can signal familial hypertriglyceridemia running through generations. This historical information, combined with your blood test results, helps your doctor make a confident diagnosis even without genetic testing in many cases.^[2][16]

Distinguishing From Secondary Causes

An important part of the diagnostic process involves ruling out or identifying secondary causes of high triglycerides—conditions or factors that aren’t genetic but can still raise triglyceride levels. Your doctor will evaluate whether you have diabetes, hypothyroidism (an underactive thyroid), kidney disease, or obesity, as all of these can elevate triglycerides. They’ll also review your medications, since certain drugs like beta-blockers, diuretics, steroids, and some birth control pills can increase triglyceride levels.^[2][11]

Your lifestyle habits will be discussed too. Excessive alcohol consumption is a well-known trigger for elevated triglycerides, as is a diet high in refined carbohydrates and sugars. Physical inactivity and being overweight also contribute to higher levels. What makes familial hypertriglyceridemia different from purely secondary causes is that even when these other factors are controlled, triglyceride levels remain elevated due to the underlying genetic predisposition. However, when genetic predisposition combines with these secondary factors, triglyceride levels can reach dangerously high values.^[2][8]

Research has identified specific biomarkers that can help distinguish familial hypertriglyceridemia from other common causes of high triglycerides. Higher concentrations of certain proteins like insulin, fibroblast growth factor 21 (FGF-21), angiopoietin-like protein 3 (ANGPTL3), and apolipoprotein A-II, combined with lower levels of apolipoprotein B, tend to be characteristic of familial hypertriglyceridemia. These measurements aren’t routinely performed in all clinics but may be available in specialized lipid centers.^[6]

Diagnostics for Clinical Trial Qualification

Genetic Testing

While not always necessary for standard clinical care, genetic testing plays an important role in research settings and clinical trials for familial hypertriglyceridemia. Scientists have identified that the condition often involves mutations in genes related to triglyceride metabolism. The most commonly implicated genetic change is a heterozygous inactivating mutation in the gene encoding for lipoprotein lipase (LPL)—an enzyme that normally breaks down triglycerides in the bloodstream. When this enzyme doesn’t work properly, triglycerides accumulate to abnormal levels.^[1][3]

Recent research has shown that familial hypertriglyceridemia likely has a polygenic basis, meaning multiple genes contribute to the condition rather than just one single gene. Researchers studying people with familial hypertriglyceridemia have analyzed panels of genetic variants—specific differences in DNA sequences—that are associated with triglyceride levels. Studies have examined dozens of these single nucleotide polymorphisms (SNPs) across the genome, finding that the cumulative effect of multiple small genetic changes contributes to elevated triglycerides in this condition.^[1][6]

For clinical trial enrollment, researchers might test for rare variants in five main genes associated with severe hypertriglyceridemia: LPL (lipoprotein lipase), APOC2 (apolipoprotein C-II), APOA5 (apolipoprotein A-V), LMF1 (lipase maturation factor 1), and GPIHBP1 (glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1). Having mutations in these genes can help identify patients who might respond particularly well to certain experimental treatments being tested in trials.^[6]

Baseline Laboratory Assessments

Clinical trials studying familial hypertriglyceridemia typically require extensive baseline laboratory testing beyond standard triglyceride measurements. Participants might need repeated fasting lipid panels taken at different times to establish consistent patterns of elevation. Trials often require that triglyceride levels fall within specific ranges—for example, persistently above 200 mg/dL but below 500 mg/dL for studies of mild to moderate disease, or consistently above 500 mg/dL for studies focusing on severe cases.^[8]

Researchers might measure additional markers to fully characterize a participant’s lipid disorder. This can include detailed particle analysis that counts the actual number of VLDL particles circulating in the blood, measurements of remnant cholesterol (leftover particles after triglycerides are removed), and assessments of various apolipoproteins. These detailed measurements help researchers understand exactly how experimental treatments affect triglyceride metabolism at multiple levels.^[6]

Assessment of Other Health Conditions

Clinical trials carefully screen for and document other health conditions that commonly occur with familial hypertriglyceridemia. Blood tests to measure fasting glucose and hemoglobin A1c (HbA1c) assess for diabetes or prediabetes. Thyroid function tests check for hypothyroidism, while kidney function tests evaluate whether chronic kidney disease is present. Blood pressure measurements and assessment for metabolic syndrome—a cluster of conditions including abdominal obesity, high blood pressure, high blood sugar, and abnormal cholesterol levels—are standard parts of trial screening.^[1][2]

These assessments serve two purposes in research settings. First, they help researchers understand whether participants have pure familial hypertriglyceridemia or a combination of genetic and secondary causes. Second, they establish baseline health status so that researchers can monitor whether experimental treatments affect these related conditions positively or negatively during the trial.^[1]

Cardiovascular Risk Assessment

Many clinical trials calculate each participant’s ten-year risk of atherosclerotic cardiovascular disease (ASCVD) using standardized risk calculators. These tools combine multiple factors—age, sex, cholesterol levels, blood pressure, smoking status, and diabetes status—to estimate the probability of having a heart attack or stroke in the next decade. Participants are often categorized into risk groups: borderline risk (5% to 7.4%), intermediate risk (7.5% to 19.9%), or high risk (20% or greater). This stratification helps researchers determine whether interventions reduce cardiovascular events differently depending on baseline risk level.^[8]

Some trials might perform imaging studies like coronary artery calcium scoring or carotid ultrasound to look for early signs of atherosclerosis even in participants who haven’t yet had cardiovascular events. These tests can identify subclinical disease—artery damage that exists but hasn’t yet caused symptoms—providing additional information about cardiovascular risk.^[8]

Pancreatitis History and Monitoring

For trials studying severe hypertriglyceridemia, researchers carefully document any history of acute pancreatitis. They’ll ask detailed questions about previous episodes, including when they occurred, how severe they were, and whether hospitalization was required. Some trials specifically enroll only patients who have experienced pancreatitis related to high triglycerides, while others might exclude such patients depending on the study goals.^[1][8]

During the trial, participants might be monitored with blood tests that measure pancreatic enzymes like amylase and lipase, which become elevated during pancreatitis. Researchers track whether experimental treatments reduce the frequency or severity of pancreatitis episodes in people prone to this complication.^[4]

Response to Previous Treatments

Researchers typically document how participants responded to standard treatments before entering a trial. This includes recording which medications (like fibrates, niacin, omega-3 fatty acids, or statins) have been tried, at what doses, for how long, and whether they successfully lowered triglycerides or caused side effects. Some trials specifically seek patients who haven’t responded adequately to standard therapies, while others might require that participants be on stable doses of certain medications before adding an experimental treatment.^[1][8]

Documentation of lifestyle modifications is also important. Trials often require that participants have attempted dietary changes and increased physical activity before qualifying for experimental medications. This ensures that researchers are testing whether new drugs provide benefits beyond what lifestyle changes alone can achieve.^[8]